UPDATE 1-U.S. FDA warns Gilead on manufacturing plant
LOS ANGELES, Sept 29 (Reuters) - The U.S. Food and Drug Administration has warned Gilead Sciences Inc about manufacturing problems at the San Dimas, California plant where drugs including the company's flagship HIV medicines are made.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here